IOHEXOL
| Brand name | IOHEXOL |
|---|---|
| Active ingredient | IOHEXOL |
| Strength | 64.7% |
| Dosage form | SOLUTION |
| Route | INJECTION, ORAL, RECTAL |
| Modality | Small molecule |
| FDA approval | November 2025 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| CGT | July 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.